PCRM Urges Alzheimer’s Researchers to Focus on Human Biology
More than 36 million people live with Alzheimer’s disease, and this number is expected to triple by 2050. Unfortunately, effective treatments remain elusive. Instead of focusing on prevention and detection, most of the research has been focused on medication and carried out on animals. Results have rarely translated into clinical benefits for patients.
At the 2014 Keystone Symposium, “Alzheimer’s Disease: From Fundamental Insights to Light at the End of the Translational Tunnel,” PCRM medical research specialist Sarah Cavanaugh, Ph.D., presented a poster discussing promising studies emphasizing the role of modifiable lifestyle factors on prevention of the disease. She also proposed a strategy for shifting the focus of basic research away from animal models to one centering on human biology as a means to improve the applicability of research findings. PCRM is working to encourage the National Institutes of Health to reflect this strategy in its funding priorities.